Tezepelumab Clinical Trials
11 recruitingBiologic
Phase 37Phase 22
Showing 1–11 of 11 trials
Recruiting
Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Asthma
AstraZeneca231 enrolled143 locationsNCT06023589
Recruiting
Phase 3
Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab
Severe Asthma
AstraZeneca400 enrolled76 locationsNCT07363642
Recruiting
Phase 2
Efficacy of Tezepelumab in Peanut Oral Immunotherapy
Peanut allergy
National Institute of Allergy and Infectious Diseases (NIAID)62 enrolled10 locationsNCT07015996
Recruiting
Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca990 enrolled268 locationsNCT06878261
Recruiting
Phase 3
A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab
Chronic Rhinosinusitis With Nasal Polyps
AstraZeneca230 enrolled21 locationsNCT07520162
Recruiting
Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca990 enrolled301 locationsNCT06883305
Recruiting
Tezspire Cardiac Events PASS
Cardiovascular EventsMACE
AstraZeneca16,640 enrolled4 locationsNCT06951867
Recruiting
Phase 3
A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With Tezepelumab
Chronic Rhinosinusitis With Nasal Polyps
AstraZeneca180 enrolled45 locationsNCT06706817
Recruiting
Observational Study on the Clinical Profile of Patients With Uncontrolled Severe Asthma Treated With Tezepelumab in Italy
Asthma
AstraZeneca300 enrolled30 locationsNCT06948396
Recruiting
Phase 2
Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPD
COPDCOPD ExacerbationImmune System Disorder+2 more
Asger Sverrild80 enrolled2 locationsNCT05507242
Recruiting
Phase 3
REVErsing Airway Remodelling With Tezepelumab
Airway Remodelling, Asthmatic
University Hospital, Montpellier90 enrolled12 locationsNCT05651841